Agenus Inc
Biotechnology company · Lexington, Massachusetts, United States · Nasdaq: AGEN
Agenus Inc is a biotechnology company headquartered in Lexington, Massachusetts, United States. Its shares trade on Nasdaq under the ticker AGEN. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $1.3 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2019.
Agenus at a glance
What does Agenus do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $1.3 million in total (2000 to 2016). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
11 Form D notices; the most recent reported $30 million sold (2019).
Frequently asked questions about Agenus
Where is Agenus headquartered?
Agenus Inc is headquartered in Lexington, Massachusetts, United States.
What does Agenus do?
Agenus Inc is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Agenus a public company?
Yes. Agenus Inc trades on Nasdaq under the ticker AGEN.
Similar companies
- Voyager Therapeutics, Inc.Lexington, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.